Oocyte morphology assessment is easy to implement in any laboratory with possible quality
grading prior to fertilization. At present, comprehensive oocyte morphology scoring is not …

Anti-Müllerian hormone (AMH) has become one of the most informative biochemical
markers of the ovary and is considered the earliest and most sensitive marker of …

Objective To compare the clinical outcomes of follicular versus luteal phase ovarian
stimulation in women with poor ovarian response (Bologna criteria) undergoing IVF …

Objectives To retrospectively analyze the correlation between anti-Müllerian hormone
(AMH) and the number of oocytes obtained by controlled ovarian hyperstimulation (COH) in …

The aims of this study were to determine anti-müllerian hormone (AMH) cutoff values for
selecting Gir (Bos taurus indicus) oocyte donors and estimate the impact of using AMH …

Purpose The objective of this study was to investigate whether women with diminished
ovarian reserve who planned for PGT-A exhibit a lower number of blastocysts for biopsy …

Background Overweight/obese women with polycystic ovary syndrome (PCOS) are at
increased risk of subfertility and complications of pregnancy, compared with normal-weight …

Purpose To determine the expected out-of-pocket costs of IVF with preimplantation genetic
testing for aneuploidy (PGT-A) to attain a 50%, 75%, or 90% likelihood of a euploid …

The aim of this study was to evaluate the predictive value of the anti-Mullerian hormone
(AMH) level for early pregnancy loss and to compare the significance of AMH level to age as …

Our objective was to study whether serum anti-Müllerian hormone (AMH) concentrations
were associated with embryo morphokinetic events. This retrospective cohort study was …